Abstract:Objective To explore the pharmacokinetics of pirarubicin and epirubicin(chemotherapeutic drugs) after continuous infusion via ear vein and internal iliac artery of rabbits.Methods Forty mature female New Zealand rabbits were randomly divided into two groups.Epirubicin was infused continually into the rabbits of first group via the ear vein or the internal iliac artery;each route of infusion included 10 animals.For the se-cond group,epirubicin was given in the same manner as epirubicin.The blood samples and the uterus tissue spe-cimens were collected at various time points during the infusion.At the end of infusion,the lung tissue,heart tissue and the fat tissue of pelvic were collected.The drug concentrations in the plasma and tissues were determined by HPLC methods.Results The peak serum concentrations of THP in the intra-arterial and intravenous group were(0.12±0.05) μg/mL and(0.16±0.10) μg/mL,respectively(P>0.05).The levels of THP in uterine tissues were not significantly different between the 2 infusion route groups(P>0.05).The area under the curve(AUC) value of THP was 0.47±0.15 in serum for intra-arterial infusion group,which was about 2/3 that of intravenous infusion group(P>0.05).The AUC value of THP in uterine tissue was 60.32±46.23 in the intra-arterial infusion group,which was similar to that in the intravenous infusion group(P>0.05).The peak serum concentrations of EPI in intra-arterial and intravenous infusion group were(0.13±0.07) μg/mL and(0.23±0.13) μg/mL,respectively(P<0.05).The levels of EPI in uterine tissues were notsignificantly diffe-rent(P>0.05);the AUC values of EPI in serum were 0.57±0.25 and 1.07±0.22,respectively(P<0.01);the AUC values of EPI in uterine tissues were 22.29±8.31 and 23.67±9.44,respectively(P>0.05).In the lung and heart tissues,the levels of THP at the end of intra-arterial infusion were about 1/2 of that at the end of intravenous infusion(P<0.01).The levels of EPI at the end of intra-arterial infusion were about 1/3 and 1/2 of those at the end of intravenous infusion(P<0.05).Conclusion Continous artery infusion of pirarubicin and epirubicin results in higher distribution in the target organs than venous infusion,but without significance.The distribution in the heart is lower than that of venous infusion.

Assay and Pharmacokinetic Analysis of Pirarubicin Injection in Mouse Plasma and Heart

Serum Metabolites of Commerical Pirarubicin Injections

Characterization and Pharmacokinetics of a Novel Pirarubicin Liposome Powder

Comparison of pharmacokinetics of pirarubicin and epirubicin after continuous infusion through ear vein and interna iliac artery of rabbits

Determination of doxorubicin in plasma and tissues of mice by UPLC-MS/MS and its application to pharmacokinetic study

Metabonomic Study on the Cumulative Cardiotoxicity of a Pirarubicin Liposome Powder

Determination of Curcumin in Plasma by HPLC and Its Pharmacokinetics in Mice

HPLC Determination of 1,3 - Diphenyl - 1,3 - Propanedione in Mouse Plasma and Its Application to Pharmacokinetic Study

Determination of Puerarin from Qingfeixiaoyan Granules in Mice Plasma by HPLC and Its Pharmacokinetic Analysis

Pharmacokinetic study with N-Ile1-Thr2-63-desulfato-r-hirudin in rabbits by means of bioassay

Determination of 4-Chloro-2-fluoro-3-methoxybenzeneboronic Acid in Rat Plasma by LC-MS/MS and Its Application in the Toxicokinetics Study

Determination of Homoplantaginin and Hispidulin in Plasma of Mice by HPLC Method

Determination of Clopidogrel and Its Metabolites in Plasma by LC-MS/MS and Its Application in the Pharmacokinetics Study in Mice

A Simple HPLC Bioanalytical Method for the Determination of Doxorubicin Hydrochloride in Rat Plasma: Application to Pharmacokinetic Studies

Development and validation of an LC-MS/MS method for the determination of ARN14988, an acid ceramidase inhibitor, and its application to a pharmacokinetic study in a mouse model

Development and Validation of a New High-Performance Liquid Chromatography-Ultraviolet Assay for Quantification of Mitoxantrone in Plasma of BALB/c-nu Mice

Development of an LC-MS/MS-based assay to determine Artemitin in rat plasma and its application in a pharmacokinetic study.

Adenylate cyclase 1 knockdown attenuates pirarubicin-induced cardiotoxicity

Study on pharmacokinetics and tissue distribution of icariside I in Rats by HPLC-UV assay

A HPLC Method for Simultaneous Determination of 5-Aminoimidazole-4-carboxamide Riboside and Its Active Metabolite 5-Aminoimidazole-4-carboxamide Ribotide in Tumor-Bearing Nude Mice Plasma and Its Application to Pharmacokinetics Study.

Simultaneous quantification of icaritin and its novel 3-methylcarbamate prodrug in rat plasma using HPLC-MS/MS and its application to pharmacokinetic study